SCHEMBL21499002

SCHEMBL21499002

CC(C)(C)CN1CCN2CCOCC2C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22304543 0.84 PDCD1LG2 (0.32)
SCHEMBL27009191 0.82 SMN1; SMN2 (0.34)
SCHEMBL21688341 0.81 GAA (0.33)
SCHEMBL3478137 0.81 GAA (0.33)
SCHEMBL21675901 0.81 GAA (0.33)
SCHEMBL24802750 0.79 SMN1; SMN2 (0.31)
SCHEMBL19159637 0.78 DRD3 (0.34)
SCHEMBL21993665 0.77
SCHEMBL23386633 0.77 POLB (0.37)
SCHEMBL23480670 0.77 POLB (0.37)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200247821-A1 MACROCYCLIC COMPOUNDS THAT INHIBIT MCL-1 PROTEIN AMGEN INC. (US) 2020-08-06 US disclosed
US-10450316-B2 Certain protein kinase inhibitor Chongqing Fochon Pharmaceutical Co., Ltd. (CN) 2019-10-22 US disclosed